Optimizing Ig Therapy Through Certification and Competency

Immunoglobulin (Ig) therapy is a highly complex, resource-intensive specialized therapy used to manage a wide range of immune-mediated conditions, including primary and secondary immunodeficiencies, autoimmune diseases, and inflammatory disorders. The increasing complexity of indications and risk factors, individualized dosing strategies, product variability, and infusion-related adverse events demands a high level of clinical expertise for safe and effective treatment.1,2